Yufan Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yufan Zhu has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Xihang Chen
Department of Plastic and Cosmetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, P. R. China
3 shared publications - Yunjun Liao
Department of Plastic and Cosmetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China
2 shared publications Feng Lu
From the Department of Plastic and Cosmetic Surgery, Nanfang Hospital, Southern Medical University , Guangzhou , China
1 shared publication- Hala Zreiqat
Tissue Engineering and Biomaterials Research Unit, School of Biomedical Engineering, Faculty of Engineering, University of Sydney, Sydney, Australia
1 shared publication Han Yang
Department of Plastic and Cosmetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, P. R. China
1 shared publicationHaojing Tang
Department of Plastic and Cosmetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, P. R. China
1 shared publication
Latest Publications
- Open Access
- 27 March 2026
- Published by Elsevier in SSRN Electronic Journal
Voronoi Curvature Scaffolds Rejuvenate Senescent Stem Cells and Enhance Aged Bone Regeneration
Ageing is associated with a progressive decline in stem cell function and regenerative capacity, contributing to impaired bone healing in elderly populations. Cellular senescence and dysregulated mechanotransduction are key factors underlying this age-related deterioration in tissue regeneration. Tissue curvature has recently emerged as an important regulator of cellular behaviour; however, its role in modulating cellular senescence and functional decline remains poorly understood. In this study, we investigate how hyperboloidal curvature regulates senescence and osteogenic differentiation in adipose tissue-derived stem cells (ASCs) and its impact on bone regeneration in vivo. Using high-resolution liquid crystal display (LCD) 3D printing, we fabricated biphasic calcium phosphate (BCP) scaffolds with distinct Gaussian curvature profiles, including Cubic, Gyroid, and Voronoi hyperboloidal architectures, and seeded senescent ASCs onto these scaffolds. ASCs cultured on Voronoi-curved scaffolds exhibited the lowest expression of cell cycle repression genes (P16, P21) and senescence-associated secretory phenotype (SASP) factors, together with markedly enhanced osteogenic differentiation. Mechanistically, Voronoi curvature suppressed αVβ3 integrin upregulation in senescent ASCs and restored mechanosensitive signalling by promoting Yes-associated protein (YAP) nuclear translocation. Blocking αVβ3 integrin signalling rejuvenated senescent ASCs and further enhanced YAP activation and osteogenesis. In an aged rat critical-sized defect model, Voronoi curvature scaffolds significantly improved bone regeneration compared with Cubic and Gyroid scaffolds. Collectively, these findings identify hyperboloidal Voronoi curvature scaffolds as a powerful geometric cue capable of rejuvenating senescent stem cells and enhancing bone repair. This work highlights scaffold geometry as a promising strategy for designing anti-senescent biomaterials to address age-related skeletal regeneration.
- 27 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessVoronoi Curvature Scaffolds Rejuvenate Senescent Stem Cells and Enhance Aged Bone Regeneration
Ageing is associated with a progressive decline in stem cell function and regenerative capacity, contributing to impaired bone healing in elderly populations. Cellular senescence and dysregulated mechanotransduction are key factors underlying this age-related deterioration in tissue regeneration. Tissue curvature has recently emerged as an important regulator of cellular behaviour; however, its role in modulating cellular senescence and functional decline remains poorly understood. In this study, we investigate how hyperboloidal curvature regulates senescence and osteogenic differentiation in adipose tissue-derived stem cells (ASCs) and its impact on bone regeneration in vivo. Using high-resolution liquid crystal display (LCD) 3D printing, we fabricated biphasic calcium phosphate (BCP) scaffolds with distinct Gaussian curvature profiles, including Cubic, Gyroid, and Voronoi hyperboloidal architectures, and seeded senescent ASCs onto these scaffolds. ASCs cultured on Voronoi-curved scaffolds exhibited the lowest expression of cell cycle repression genes (P16, P21) and senescence-associated secretory phenotype (SASP) factors, together with markedly enhanced osteogenic differentiation. Mechanistically, Voronoi curvature suppressed αVβ3 integrin upregulation in senescent ASCs and restored mechanosensitive signalling by promoting Yes-associated protein (YAP) nuclear translocation. Blocking αVβ3 integrin signalling rejuvenated senescent ASCs and further enhanced YAP activation and osteogenesis. In an aged rat critical-sized defect model, Voronoi curvature scaffolds significantly improved bone regeneration compared with Cubic and Gyroid scaffolds. Collectively, these findings identify hyperboloidal Voronoi curvature scaffolds as a powerful geometric cue capable of rejuvenating senescent stem cells and enhancing bone repair. This work highlights scaffold geometry as a promising strategy for designing anti-senescent biomaterials to address age-related skeletal regeneration.
- Open Access
- 24 March 2025
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 23 (1) , 1-21
Mesenchymal stem cells-derived small extracellular vesicles and apoptotic extracellular vesicles for wound healing and skin regeneration: a systematic review and meta-analysis of preclinical studies
Studies examining the therapeutic potential of Mesenchymal stem cells-derived extracellular vesicles (MSC-EVs) in wound healing and skin regeneration have progressed rapidly. Prior to considering clinical translation, a systematic and comprehensive understanding of these experimental details and the overall impact of MSC-EVs on skin regeneration is necessary. 83 studies were identified in Web of Science, Embase, and PubMed that satisfied a set of prespecified inclusion criteria. A random effects meta-analysis was conducted for wound closure rate, scar width, blood vessel density and collagen deposition. Our findings demonstrate clear potential of MSC-EVs to be developed as therapy for wound healing and skin regeneration both in diabetic and non-diabetic animal models. Moreover, subgroup analyses demonstrated that apoptotic small extracellular vesicles (ApoSEVs) showed better efficacy than apoptotic bodies (ApoBDs) and small extracellular vesicles (sEVs) in wound closure outcome and collagen deposition, while sEVs displayed better than ApoEVs in revascularization. Among frequently used routes of administration, subcutaneous injection displayed a greater improvement to wound closure, collagen deposition and revascularization as compared to dressing/covering. Among easier-access source of MSCs, ADSCs demonstrated the best effect in wound closure rate and collagen deposition, as compared, BMMSCs displayed better in revascularization. Additionally, high heterogeneity observed in collection conditions, separation methods, storage methods, modifications, treatment dose, administration route, and frequency of MSC-EVs underscores the urgent need for standardization in these areas, prior to clinical translation. PROSPERO CRD42024499172.
- 24 March 2025
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 23 (1) , 1-21
Open AccessMesenchymal stem cells-derived small extracellular vesicles and apoptotic extracellular vesicles for wound healing and skin regeneration: a systematic review and meta-analysis of preclinical studies
Studies examining the therapeutic potential of Mesenchymal stem cells-derived extracellular vesicles (MSC-EVs) in wound healing and skin regeneration have progressed rapidly. Prior to considering clinical translation, a systematic and comprehensive understanding of these experimental details and the overall impact of MSC-EVs on skin regeneration is necessary. 83 studies were identified in Web of Science, Embase, and PubMed that satisfied a set of prespecified inclusion criteria. A random effects meta-analysis was conducted for wound closure rate, scar width, blood vessel density and collagen deposition. Our findings demonstrate clear potential of MSC-EVs to be developed as therapy for wound healing and skin regeneration both in diabetic and non-diabetic animal models. Moreover, subgroup analyses demonstrated that apoptotic small extracellular vesicles (ApoSEVs) showed better efficacy than apoptotic bodies (ApoBDs) and small extracellular vesicles (sEVs) in wound closure outcome and collagen deposition, while sEVs displayed better than ApoEVs in revascularization. Among frequently used routes of administration, subcutaneous injection displayed a greater improvement to wound closure, collagen deposition and revascularization as compared to dressing/covering. Among easier-access source of MSCs, ADSCs demonstrated the best effect in wound closure rate and collagen deposition, as compared, BMMSCs displayed better in revascularization. Additionally, high heterogeneity observed in collection conditions, separation methods, storage methods, modifications, treatment dose, administration route, and frequency of MSC-EVs underscores the urgent need for standardization in these areas, prior to clinical translation. PROSPERO CRD42024499172.
- 26 May 2024
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 44 (8) , NP585-NP605
Inhibition of Adipocyte Necroptosis Alleviates Fat Necrosis and Fibrosis After Grafting in a Murine Model
Owing to the delicate structure of the adipose tissue, fat necrosis accounts for 43.7% of all complications after autologous fat grafting; however, its regulation remains unclear. The purpose of this study was to examine the role of necroptosis in fat graft remodeling after grafting. Clinical fat graft necrosis samples were collected, and the expression levels of the necroptosis marker phosphorylated(p)-MLKL were analyzed. Transcriptome analysis was performed on fat grafts before and one week after transplantation in C57BL/6 mouse fat grafting models. Additionally, the in vivo effects of RIPK1 inhibitor Nec-1s or RIPK3 inhibitor GSKʹ872 on the fat grafting complications including fat necrosis and fibrosis were investigated. Necroptosis markers were observed and associated with higher occurrence of fibrosis in clinical fat graft necrosis samples compared to normal fat tissue. Amplification and RNA-Seq were conducted on RNA isolated from fat grafts before and after grafting. MLKL, RIPK1 and RIPK3 expression levels were significantly upregulated in comparison to controls. Higher expression levels of necroptotic RNAs were associated with higher levels of DAMPs, including Cxcl2, HMGB1, S100a8, S100a9, Nlrp3 and IL33, and activated pro-inflammatory signaling pathways, including the TNF, NF-kappa B and chemokine signaling pathways. Necroptotic inhibitor Nec-1s and GSKʹ872 robustly suppressed the p-MLKL expression level and significantly inhibited necroptotic cell death, especially in adipocytes. Moreover, administration of Nec-1s and GSKʹ872 significantly alleviated fat necrosis and subsequent fibrosis in fat grafts. Collectively, our study findings highlight the potential therapeutic applications of necroptosis inhibitors in preventing fat necrosis and fibrosis after grafting.
- 26 May 2024
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 44 (8) , NP585-NP605
Inhibition of Adipocyte Necroptosis Alleviates Fat Necrosis and Fibrosis After Grafting in a Murine Model
Owing to the delicate structure of the adipose tissue, fat necrosis accounts for 43.7% of all complications after autologous fat grafting; however, its regulation remains unclear. The purpose of this study was to examine the role of necroptosis in fat graft remodeling after grafting. Clinical fat graft necrosis samples were collected, and the expression levels of the necroptosis marker phosphorylated(p)-MLKL were analyzed. Transcriptome analysis was performed on fat grafts before and one week after transplantation in C57BL/6 mouse fat grafting models. Additionally, the in vivo effects of RIPK1 inhibitor Nec-1s or RIPK3 inhibitor GSKʹ872 on the fat grafting complications including fat necrosis and fibrosis were investigated. Necroptosis markers were observed and associated with higher occurrence of fibrosis in clinical fat graft necrosis samples compared to normal fat tissue. Amplification and RNA-Seq were conducted on RNA isolated from fat grafts before and after grafting. MLKL, RIPK1 and RIPK3 expression levels were significantly upregulated in comparison to controls. Higher expression levels of necroptotic RNAs were associated with higher levels of DAMPs, including Cxcl2, HMGB1, S100a8, S100a9, Nlrp3 and IL33, and activated pro-inflammatory signaling pathways, including the TNF, NF-kappa B and chemokine signaling pathways. Necroptotic inhibitor Nec-1s and GSKʹ872 robustly suppressed the p-MLKL expression level and significantly inhibited necroptotic cell death, especially in adipocytes. Moreover, administration of Nec-1s and GSKʹ872 significantly alleviated fat necrosis and subsequent fibrosis in fat grafts. Collectively, our study findings highlight the potential therapeutic applications of necroptosis inhibitors in preventing fat necrosis and fibrosis after grafting.
- 20 June 2023
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 41 (9) , 837-849
Mesenchymal Stem Cells-Derived Apoptotic Extracellular Vesicles (ApoEVs): Mechanism and Application in Tissue Regeneration
Mesenchymal stem cells (MSCs) are commonly used as a source for cellular therapy owing to their strong immunosuppressive and regenerative effects. However, MSCs undergo extensive apoptosis within a short period after transplantation. During apoptosis, MSCs generate several apoptotic extracellular vesicles (MSCs-ApoEVs). MSCs-ApoEVs are rich in miRNomes, metabolites, and proteomes. They are critical intercellular communication mediators that can exert different regulatory effects on recipient cells. MSCs-ApoEVs have been shown to promote regeneration in the skin, hair, bone, muscle, and vascular system, etc. This review describes the production, release, isolation, and functionality of ApoEVs in detail. Furthermore, we summarize the existing mechanisms of MSCs-ApoEVs used for tissue regeneration and evaluate the possible strategies for their clinical application.
- 20 June 2023
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 41 (9) , 837-849
Mesenchymal Stem Cells-Derived Apoptotic Extracellular Vesicles (ApoEVs): Mechanism and Application in Tissue Regeneration
Mesenchymal stem cells (MSCs) are commonly used as a source for cellular therapy owing to their strong immunosuppressive and regenerative effects. However, MSCs undergo extensive apoptosis within a short period after transplantation. During apoptosis, MSCs generate several apoptotic extracellular vesicles (MSCs-ApoEVs). MSCs-ApoEVs are rich in miRNomes, metabolites, and proteomes. They are critical intercellular communication mediators that can exert different regulatory effects on recipient cells. MSCs-ApoEVs have been shown to promote regeneration in the skin, hair, bone, muscle, and vascular system, etc. This review describes the production, release, isolation, and functionality of ApoEVs in detail. Furthermore, we summarize the existing mechanisms of MSCs-ApoEVs used for tissue regeneration and evaluate the possible strategies for their clinical application.